CD8+ T Cells from Mice Transnuclear for a TCR that Recognizes a Single H-2Kb-Restricted MHV68 Epitope Derived from gB-ORF8 Help Control Infection

Cell Reports

Volumn 1, Issue 5, 2012, Pages 461-471

  Sehrawat, Sharvan ^a   Kirak, Oktay ^d   Koenig, Paul Albert ^a   Isaacson, Marisa K ^a   Marques, Sofia ^b,c   Bozkurt, Gunes ^a   Simas, J Pedro ^b,c   Jaenisch, Rudolph ^a   Ploegh, Hidde L ^a  

^a WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^b INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^c INSTITUTO GULBENKIAN DE CIÊNCIA   (Portugal)

^d SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN RECOGNITION; ARTICLE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; EMBRYO; EX VIVO STUDY; HERPES VIRUS; HERPES VIRUS INFECTION; IMMUNOSTIMULATION; IN VIVO STUDY; LYMPHOCYTOPENIA; MOUSE; MURINE HERPES VIRUS 68; NONHUMAN; OPEN READING FRAME; PHENOTYPE; VIRUS IMMUNITY; VIRUS LOAD;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELL NUCLEUS; CELL PROLIFERATION; EPITOPES; GLYCOPROTEINS; H-2 ANTIGENS; HERPESVIRIDAE INFECTIONS; HOMEODOMAIN PROTEINS; MICE; MICE, INBRED STRAINS; MICE, KNOCKOUT; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; PHENOTYPE; RECEPTORS, ANTIGEN, T-CELL; RHADINOVIRUS; TUMOR VIRUS INFECTIONS; VIRAL LOAD; VIRAL PROTEINS;

HERPESVIRIDAE; MURINE HEPATITIS VIRUS; MUS;

EID: 84861695392     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2012.03.009     Document Type: Article

References (38)

1. Andreansky S., Liu H., Adler H., Koszinowski U.H., Efstathiou S., Doherty P.C. The limits of protection by " memory" T cells in Ig-/- mice persistently infected with a gamma-herpesvirus. Proc. Natl. Acad. Sci. USA 2004, 101:2017-2022.
2. Barton E., Mandal P., Speck S.H. Pathogenesis and host control of gammaherpesviruses: lessons from the mouse. Annu. Rev. Immunol. 2011, 29:351-397.
3. Belz G.T., Stevenson P.G., Castrucci M.R., Altman J.D., Doherty P.C. Postexposure vaccination massively increases the prevalence of gamma-herpesvirus-specific CD8+ T cells but confers minimal survival advantage on CD4-deficient mice. Proc. Natl. Acad. Sci. USA 2000, 97:2725-2730.
4. Cush S.S., Anderson K.M., Ravneberg D.H., Weslow-Schmidt J.L., Flaño E. Memory generation and maintenance of CD8+ T cell function during viral persistence. J. Immunol. 2007, 179:141-153.
5. Flaño E., Woodland D.L., Blackman M.A. A mouse model for infectious mononucleosis. Immunol. Res. 2002, 25:201-217.
6. Freeman M.L., Lanzer K.G., Cookenham T., Peters B., Sidney J., Wu T.T., Sun R., Woodland D.L., Sette A., Blackman M.A. Two kinetic patterns of epitope-specific CD8 T-cell responses following murine gammaherpesvirus 68 infection. J. Virol. 2010, 84:2881-2892.
7. Fuse S., Bellfy S., Yagita H., Usherwood E.J. CD8+ T cell dysfunction and increase in murine gammaherpesvirus latent viral burden in the absence of 4-1BB ligand. J. Immunol. 2007, 178:5227-5236.
8. Goldrath A.W., Bogatzki L.Y., Bevan M.J. Naive T cells transiently acquire a memory-like phenotype during homeostasis-driven proliferation. J. Exp. Med. 2000, 192:557-564.
9. Gray D. A role for antigen in the maintenance of immunological memory. Nat. Rev. Immunol. 2002, 2:60-65.
10. Gredmark-Russ S., Cheung E.J., Isaacson M.K., Ploegh H.L., Grotenbreg G.M. The CD8 T-cell response against murine gammaherpesvirus 68 is directed toward a broad repertoire of epitopes from both early and late antigens. J. Virol. 2008, 82:12205-12212.
11. Horst D., Ressing M.E., Wiertz E.J. Exploiting human herpesvirus immune evasion for therapeutic gain: potential and pitfalls. Immunol. Cell Biol. 2011, 89:359-366.
12. Kaech S.M., Tan J.T., Wherry E.J., Konieczny B.T., Surh C.D., Ahmed R. Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat. Immunol. 2003, 4:1191-1198.
13. Kirak O., Frickel E.M., Grotenbreg G.M., Suh H., Jaenisch R., Ploegh H.L. Transnuclear mice with predefined T cell receptor specificities against Toxoplasma gondii obtained via SCNT. Science 2010, 328:243-248.
14. Klenerman P., Hill A. T cells and viral persistence: lessons from diverse infections. Nat. Immunol. 2005, 6:873-879.
15. Liu L., Flaño E., Usherwood E.J., Surman S., Blackman M.A., Woodland D.L. Lytic cycle T cell epitopes are expressed in two distinct phases during MHV-68 infection. J. Immunol. 1999, 163:868-874.
16. Liu L., Usherwood E.J., Blackman M.A., Woodland D.L. T-cell vaccination alters the course of murine herpesvirus 68 infection and the establishment of viral latency in mice. J. Virol. 1999, 73:9849-9857.
17. Long H.M., Taylor G.S., Rickinson A.B. Immune defence against EBV and EBV-associated disease. Curr. Opin. Immunol. 2011, 23:258-264.
18. Mareeva T., Martinez-Hackert E., Sykulev Y. How a T cell receptor-like antibody recognizes major histocompatibility complex-bound peptide. J. Biol. Chem. 2008, 283:29053-29059.
19. Marques S., Alenquer M., Stevenson P.G., Simas J.P. A single CD8+ T cell epitope sets the long-term latent load of a murid herpesvirus. PLoS Pathog. 2008, 4:e1000177.
20. Molloy M.J., Zhang W., Usherwood E.J. Suppressive CD8+ T cells arise in the absence of CD4 help and compromise control of persistent virus. J. Immunol. 2011, 186:6218-6226.
21. Morens D.M., Folkers G.K., Fauci A.S. The challenge of emerging and re-emerging infectious diseases. Nature 2004, 430:242-249.
22. Murali-Krishna K., Ahmed R. Cutting edge: naive T cells masquerading as memory cells. J. Immunol. 2000, 165:1733-1737.
23. Nash A.A., Sunil-Chandra N.P. Interactions of the murine gammaherpesvirus with the immune system. Curr. Opin. Immunol. 1994, 6:560-563.
24. Obar J.J., Crist S.G., Gondek D.C., Usherwood E.J. Different functional capacities of latent and lytic antigen-specific CD8 T cells in murine gammaherpesvirus infection. J. Immunol. 2004, 172:1213-1219.
25. Obar J.J., Crist S.G., Leung E.K., Usherwood E.J. IL-15-independent proliferative renewal of memory CD8+ T cells in latent gammaherpesvirus infection. J. Immunol. 2004, 173:2705-2714.
26. Rickinson A.B., Moss D.J. Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection. Annu. Rev. Immunol. 1997, 15:405-431.
27. Rouse B.T., Sehrawat S. Immunity and immunopathology to viruses: what decides the outcome?. Nat. Rev. Immunol. 2010, 10:514-526.
28. Ruckwardt T.J., Luongo C., Malloy A.M., Liu J., Chen M., Collins P.L., Graham B.S. Responses against a subdominant CD8+ T cell epitope protect against immunopathology caused by a dominant epitope. J. Immunol. 2010, 185:4673-4680.
29. Sehrawat S., Reddy P.B., Rajasagi N., Suryawanshi A., Hirashima M., Rouse B.T. Galectin-9/TIM-3 interaction regulates virus-specific primary and memory CD8 T cell response. PLoS Pathog. 2010, 6:e1000882.
30. Simas J.P., Efstathiou S. Murine gammaherpesvirus 68: a model for the study of gammaherpesvirus pathogenesis. Trends Microbiol. 1998, 6:276-282.
31. Speiser D.E., Wieckowski S., Gupta B., Iancu E.M., Baumgaertner P., Baitsch L., Michielin O., Romero P., Rufer N. Single cell analysis reveals similar functional competence of dominant and nondominant CD8 T-cell clonotypes. Proc. Natl. Acad. Sci. USA 2011, 108:15318-15323.
32. van der Burg S.H., Arens R., Melief C.J. Immunotherapy for persistent viral infections and associated disease. Trends Immunol. 2011, 32:97-103.
33. Van Kaer L., Ashton-Rickardt P.G., Ploegh H.L., Tonegawa S. TAP1 mutant mice are deficient in antigen presentation, surface class I molecules, and CD4-8+ T cells. Cell 1992, 71:1205-1214.
34. Virgin H.W., Wherry E.J., Ahmed R. Redefining chronic viral infection. Cell 2009, 138:30-50.
35. Virgin H.W., Latreille P., Wamsley P., Hallsworth K., Weck K.E., Dal Canto A.J., Speck S.H. Complete sequence and genomic analysis of murine gammaherpesvirus 68. J. Virol. 1997, 71:5894-5904.
36. Welsh R.M., Fujinami R.S. Pathogenic epitopes, heterologous immunity and vaccine design. Nat. Rev. Microbiol. 2007, 5:555-563.
37. Woodland D.L., Usherwood E.J., Liu L., Flaño E., Kim I.J., Blackman M.A. Vaccination against murine gamma-herpesvirus infection. Viral Immunol. 2001, 14:217-226.
38. Wu T.T., Blackman M.A., Sun R. Prospects of a novel vaccination strategy for human gamma-herpesviruses. Immunol. Res. 2010, 48:122-146.